CDEK by Data4ThePeople

Sign in Sign up

← All organizations

Kringle Pharma, Inc.

For profitWebsite ↗

Also known as: Kringle Pharma Europe AB | Kringle Pharma, Inc.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Nov 18, 2022

Timeline

2000s

Jun 1, 2001
Kringle Pharma, Inc.— Founded

Drugs by trial phase (2 distinct, 4 trials)

Phase 3 (1 own, 0 via acquisition)

Hepatocyte Growth Factor

Phase 2 (1 own, 0 via acquisition)

chronseal

Indications

Studied for

Recent trials (8)

NCT05627648Lead sponsorPhase 3Nov 18, 2022
NCT05627648Study directorPhase 3Nov 18, 2022
NCT04475224Study directorPhase 3Jul 13, 2020
NCT04475224Lead sponsorPhase 3Jul 13, 2020
NCT02193334Study directorPhase 1/Phase 2Jun 1, 2014
NCT02193334Lead sponsorPhase 1/Phase 2Jun 1, 2014
NCT00797706CollaboratorPhase 1/Phase 2Nov 1, 2008
NCT00797706Lead sponsorPhase 1/Phase 2Nov 1, 2008

Details

Founded: Toyonaka, JP Jun 1, 2001
Last known activity: Nov 18, 2022